🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Exogenous lactate infusion enhanced VMH neuroplasticity and visceral fat reduction via PGC-1α-ERα pathway in female rats.

PMID: 41417064 · DOI: 10.1007/s00421-025-06097-2 · European journal of applied physiology, 2025 · Shuai Tian, Jing Han, Zhaomin Zhang, Jinchan Du, Wei Chen, Yang Liu
📄 Abstract

High-intensity exercise promotes visceral adipose tissue (VAT) breakdown in females via the hypothalamic ERα pathway, and exogenous lactate infusion combined with aerobic training (AT) mimics this effect. However, whether lactate administration can independently mediate hypothalamic plasticity and VAT catabolism as a standalone nutritional strategy remains unexplored. Firstly, using a two-factor design (Lactate × AT) in female SD rats, we showed that long-term exogenous lactate infusion independently induced co-expression of Estrogen receptor α (ERα) and Brain-derived neurotrophic factor (BDNF) in the ventromedial hypothalamus (VMH) and elevated local field potential spectral power in specific bands. These neural adaptations were accompanied by increased resting metabolic rate, enhanced fat oxidation, and enhanced lipolysis, thereby preventing excessive VAT accumulation induced by a high-fat diet. Furthermore, pharmacological inhibition confirmed that Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-α (PGC-1α) acts as a co-upstream signal of ERα and BDNF mediating this process. Our findings reveal that standalone lactate administration induces functional plasticity and metabolic reprogramming through the VMH PGC-1α-ERα pathway, independent of exercise, and effectively suppresses pathological VAT accumulation in female rats. This study identifies potential nutritional interventions and mechanistic targets for preventing female-centered obesity.

Confidence: 0.44 · 23 полей извлечено
Идентификация (6 полей)
Target
PGC-1α
0.95
Alt. target
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-α
0.95
Protein family
Transcriptional coactivator
0.80
Functional class
Transcriptional coactivator
0.80
Subcellular loc.
0.00
Isoforms (metab/obesity)
0.00
Механизм действия (21 полей)
Mechanism
Lactate induces co-expression of ERα and BDNF in the VMH via PGC-1α, leading to increased resting metabolic rate, enhanced fat oxidation, and enhanced lipolysis, thereby preventing excessive VAT accumulation.
0.95
Mutations (obesity/lean)
0.00
Activity (obesity)
Lactate administration prevents excessive VAT accumulation induced by a high-fat diet.
0.90
Activity temporal
0.00
Energy balance
Increases resting metabolic rate and enhances fat oxidation.
0.90
Appetite
0.00
Fat metabolism
Enhances fat oxidation and lipolysis, preventing VAT accumulation.
0.90
Lipolysis
Enhances lipolysis.
0.90
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
0.00
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
Involves ERα pathway in the VMH.
0.90
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
PGC-1α acts as a co-upstream signal of ERα and BDNF.
0.90
Upstream (physiol)
Exogenous lactate infusion.
0.90
Downstream (biochem)
ERα and BDNF in the VMH.
0.90
Downstream (physiol)
Increased resting metabolic rate, enhanced fat oxidation, enhanced lipolysis, prevention of VAT accumulation.
0.90
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
ERα and BDNF co-expression in ventromedial hypothalamus (VMH)
0.90
In vitro
0.00
In vivo
Female SD rats with two-factor design (Lactate × AT); long-term exogenous lactate infusion; pharmacological inhibition of PGC-1α
0.95
In silico
0.00
Genetic association
0.00
Ex vivo
0.00
Animal model
Female Sprague-Dawley (SD) rats
0.95
Diet/model
High-fat diet
0.90
Клиника (11 полей)
Drug
lactate
0.90
Indication
prevention of excessive visceral adipose tissue accumulation induced by high-fat diet
0.80
Patient subgroups
females
0.70
Safety concerns
0.00
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
induces co-expression of ERα and BDNF in the ventromedial hypothalamus via PGC-1α pathway, leading to increased resting metabolic rate, enhanced fat oxidation, and enhanced lipolysis
0.90
Endpoints
0.00
Approved
False
0.80